To assess BRCA1 methylation in breast cancer patients, we included all patients enrolled in three neoadjuvant breast cancer studies (the EPITAX, DDP, and PETREMAC trials) [8, 28, 29] from whom pretreatment tumor tissue and matched WBC DNA samples were available. Here, BRCA1 is linked to breast carcinoma.